Autopsy report · NCT03029442

The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury

“Study ended early due to COVID-19”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 5 years 6 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

James J. Peters Veterans Affairs Medical Center

Sponsor type

US federal agency

Conditions

Secondary Osteoporosis; Spinal Cord Injury

Interventions

Denosumab (Prolia); Placebo (normal saline)

Participants

5

Sites

2

Countries

United States

Trials that died the same way

• Effects of Community-center Based Dietary Intervention on Frailty Prevention and Regression in the Elderly.
  “Due to the impacts of COVID-19, the study had to terminate.” (84% match in meaning)
• New Formulations of Propafenone to Treat Atrial Fibrillation
  “Study halted/terminated prematurely due to COVID.” (82% match in meaning)
• Camp Based Multi-component Intervention for Families of Young Children With Type 1 Diabetes
  “Study terminated due to COVID-19 pandemic” (82% match in meaning)
• RAman For Thyroid cancER
  “Covid19 halted study” (82% match in meaning)
• Improving 24-hour Blood Pressure in Obstructive Sleep Apnea
  “Covid-19 Pandemic prevented this study from beginning” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.